Lv31
338 积分 2023-07-05 加入
Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
1小时前
已完结
Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study
1个月前
已完结
Precision treatment guided by patient-derived organoids-based drug testing for locally advanced thyroid cancer: a single arm, phase 2 study
1个月前
已完结
Progression-Free Survival: Meaningful or Simply Measurable?
3个月前
已关闭
EGFR activation limits the response of liver cancer to lenvatinib
3个月前
已完结
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
3个月前
已完结
Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
3个月前
已关闭
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma
4个月前
已完结
Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma
4个月前
已完结
Effect of different PD‐1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
4个月前
已完结
皖公网安备34019202002308
